Shanghai Haohai Biological Technology Co., Ltd. (6826.HK) HKSE

25.52

-0.02(-0.08%)

Updated at December 24 12:08PM

Currency In HKD

Valuation

Market Cap5.83B
Enterprise Value3.65B
P/E Ratio26.49
PEG Ratio-11.33
Price/Sales Ratio3.4
Price/Book Ratio1.81
Enterprise/Revenue2.56
Enterprise/EBITDA13.57

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.15
Operating Margin-0.04

Management Effectiveness

Return On Assets0.05
Return On Equity0.07

Income Statement

Revenue2.68B
Revenue/Share10.95
Gross Profit1.87B
EBITDA549.05M
Net Income420.45M
Diluted EPS1.8

Balance Sheet

Total Cash2.84B
Total Cash/Share11.39
Total Debt451.27M
Total Debt/Equity0.07
Current Ratio3.77
Book Value Per Share25.8

Price History

52-Week Change-5.48
52-Week High34.35
52-Week Low21.7
Moving Average 50 Days27.09
Moving Average 200 Days26.82

Statistics

Average Volume214,561
Shares Outstanding402.93M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate1
Trailing Annual Dividend Yield2.24
Payout Ratio0.89
Last Split Factor7:5
Last Split DateJune 06, 2024